Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 March 2004, Vol. 103, No. 6, pp. 2238-2247.
Prepublished online as a Blood First Edition Paper on November 26, 2003; DOI 10.1182/blood-2003-08-2765.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-08-2765v1
103/6/2238    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zaunders, J. J.
Right arrow Articles by Kelleher, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zaunders, J. J.
Right arrow Articles by Kelleher, A. D.
Related Collections
Right arrow Immunobiology
Right arrow Chemokines, Cytokines, and Interleukins
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

IMMUNOBIOLOGY

Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection

John J. Zaunders, Wayne B. Dyer, Bin Wang, Mee Ling Munier, Monica Miranda-Saksena, Rebecca Newton, John Moore, Charles R. Mackay, David A. Cooper, Nitin K. Saksena, and Anthony D. Kelleher

From the Centre for Immunology, St Vincent's Hospital and University of New South Wales, Sydney, Australia; Viral Immunology Laboratory, Tissue Typing Department, Australian Red Cross Blood Service, Sydney, Australia; Retroviral Genetics Laboratory, Centre for Virus Research, Westmead Millennium Institute, Westmead Hospital and University of Sydney, Sydney, Australia; National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia; Garvan Institute, Sydney, Australia; and the Haematology Department, St Vincent's Hospital, Sydney, Australia.

Antigen-specific CD4+ effector T cells primarily provide help for B-cell antibody responses and CD8+ cytotoxic T-lymphocyte (CTL) responses. We have found an expanded population of HIV-1 p24-specific, T-cell receptor Vbeta17+, CD4+ T lymphocytes, defined by in vitro proliferative and interferon-{gamma} responses to a 15-mer Gag peptide, in the peripheral blood of an individual with long-term nonprogressive HIV-1 infection. Ex vivo, these cells were CCR5+ and CCR7-, consistent with an effector/memory function. Surprisingly, these cells highly expressed several proteins characteristic of cytotoxic lymphocytes, including TIA-1 (T-cell intracellular antigen 1; GMP-17/NKG7), granzymes A and B, CD161 (NKRP-1), and CD244 (C1.7/2B4). Following in vitro peptide stimulation, these cells produced interleukin 2 (IL-2) and intracellular CD40L, suggesting possible helper function, in addition to induction of perforin and cytotoxicity. A subset of cytomegalovirus (CMV)–specific CD4+ T cells in healthy adults similarly expressed these CTL markers and CCR5, ex vivo. Furthermore, this distinct subset of CD4+ T cells was significantly elevated in healthy CMV-seropositive adults, compared with CMV-seronegative individuals. These results suggest that CCR5+ CD4+ CTL may be a major effector mechanism of the immune response to viral infections in humans. Moreover, expression of CCR5 may render them particularly susceptible to cytopathic effects during progressive HIV-1 infection.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
I. Karlsson, B. Malleret, P. Brochard, B. Delache, J. Calvo, R. Le Grand, and B. Vaslin
Dynamics of T-Cell Responses and Memory T Cells during Primary Simian Immunodeficiency Virus Infection in Cynomolgus Macaques
J. Virol., December 15, 2007; 81(24): 13456 - 13468.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. J. Potter, C. Lacabaratz, O. Lambotte, S. Perez-Patrigeon, B. Vingert, M. Sinet, J.-H. Colle, A. Urrutia, D. Scott-Algara, F. Boufassa, et al.
Preserved Central Memory and Activated Effector Memory CD4+ T-Cell Subsets in Human Immunodeficiency Virus Controllers: an ANRS EP36 Study
J. Virol., December 15, 2007; 81(24): 13904 - 13915.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Appay, A. Bosio, S. Lokan, Y. Wiencek, C. Biervert, D. Kusters, E. Devevre, D. Speiser, P. Romero, N. Rufer, et al.
Sensitive Gene Expression Profiling of Human T Cell Subsets Reveals Parallel Post-Thymic Differentiation for CD4+ and CD8+ Lineages
J. Immunol., December 1, 2007; 179(11): 7406 - 7414.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. A. Brown, J. L. Hurwitz, A. Zirkel, S. Surman, T. Takimoto, I. Alymova, C. Coleclough, A. Portner, P. C. Doherty, and K. S. Slobod
A Recombinant Sendai Virus Is Controlled by CD4+ Effector T Cells Responding to a Secreted Human Immunodeficiency Virus Type 1 Envelope Glycoprotein
J. Virol., November 15, 2007; 81(22): 12535 - 12542.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. Delmas, P. Brousset, D. Clement, E. Le Roy, and J.-L. Davignon
Anti-IE1 CD4+ T-cell clones kill peptide-pulsed, but not human cytomegalovirus-infected, target cells
J. Gen. Virol., September 1, 2007; 88(9): 2441 - 2449.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. Tanijiri, T. Shimizu, K. Uehira, T. Yokoi, H. Amuro, H. Sugimoto, Y. Torii, K. Tajima, T. Ito, R. Amakawa, et al.
Hodgkin's Reed-Sternberg cell line (KM-H2) promotes a bidirectional differentiation of CD4+CD25+Foxp3+ T cells and CD4+ cytotoxic T lymphocytes from CD4+ naive T cells
J. Leukoc. Biol., September 1, 2007; 82(3): 576 - 584.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Garrido, F. Ruiz-Cabello, P. Barcena, Y. Sandberg, J. Canton, M. Lima, A. Balanzategui, M. Gonzalez, M. A. Lopez-Nevot, A. W. Langerak, et al.
Monoclonal TCR-V 13.1+/CD4+/NKa+/CD8 /+dim T-LGL lymphocytosis: evidence for an antigen-driven chronic T-cell stimulation origin
Blood, June 1, 2007; 109(11): 4890 - 4898.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. P. Casazza, M. R. Betts, D. A. Price, M. L. Precopio, L. E. Ruff, J. M. Brenchley, B. J. Hill, M. Roederer, D. C. Douek, and R. A. Koup
Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation
J. Exp. Med., December 25, 2006; 203(13): 2865 - 2877.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M.-C. Gauduin, Y. Yu, A. Barabasz, A. Carville, M. Piatak, J. D. Lifson, R. C. Desrosiers, and R. P. Johnson
Induction of a virus-specific effector-memory CD4+ T cell response by attenuated SIV infection
J. Exp. Med., November 27, 2006; 203(12): 2661 - 2672.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. J. Zaunders, W. B. Dyer, M. L. Munier, S. Ip, J. Liu, E. Amyes, W. Rawlinson, R. De Rose, S. J. Kent, J. S. Sullivan, et al.
CD127+CCR5+CD38+++ CD4+ Th1 Effector Cells Are an Early Component of the Primary Immune Response to Vaccinia Virus and Precede Development of Interleukin-2+ Memory CD4+ T Cells.
J. Virol., October 1, 2006; 80(20): 10151 - 10161.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. J. Zaunders, S. Ip, M. L. Munier, D. E. Kaufmann, K. Suzuki, C. Brereton, S. C. Sasson, N. Seddiki, K. Koelsch, A. Landay, et al.
Infection of CD127+ (Interleukin-7 Receptor+) CD4+ Cells and Overexpression of CTLA-4 Are Linked to Loss of Antigen-Specific CD4 T Cells during Primary Human Immunodeficiency Virus Type 1 Infection.
J. Virol., October 1, 2006; 80(20): 10162 - 10172.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Chtanova, R. Newton, S. M. Liu, L. Weininger, T. R. Young, D. G. Silva, F. Bertoni, A. Rinaldi, S. Chappaz, F. Sallusto, et al.
Identification of T Cell-Restricted Genes, and Signatures for Different T Cell Responses, Using a Comprehensive Collection of Microarray Datasets
J. Immunol., December 15, 2005; 175(12): 7837 - 7847.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. J. Zaunders, M. L. Munier, D. E. Kaufmann, S. Ip, P. Grey, D. Smith, T. Ramacciotti, D. Quan, R. Finlayson, J. Kaldor, et al.
Early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector cells during primary HIV-1 infection
Blood, September 1, 2005; 106(5): 1660 - 1667.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Assarsson, T. Kambayashi, C. M. Persson, B. J. Chambers, and H.-G. Ljunggren
2B4/CD48-Mediated Regulation of Lymphocyte Activation and Function
J. Immunol., August 15, 2005; 175(4): 2045 - 2049.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Alvaro, M. Lejeune, M. T. Salvado, R. Bosch, J. F. Garcia, J. Jaen, A. H. Banham, G. Roncador, C. Montalban, and M. A. Piris
Outcome in Hodgkin's Lymphoma Can Be Predicted from the Presence of Accompanying Cytotoxic and Regulatory T Cells
Clin. Cancer Res., February 15, 2005; 11(4): 1467 - 1473.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. J. Norris, H. F. Moffett, O. O. Yang, D. E. Kaufmann, M. J. Clark, M. M. Addo, and E. S. Rosenberg
Beyond Help: Direct Effector Functions of Human Immunodeficiency Virus Type 1-Specific CD4+ T Cells
J. Virol., August 15, 2004; 78(16): 8844 - 8851.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020